breakthrough in bid to prevent diabetes, page-6

Dear Ptolemy,
My guess is that apollo have already used their oral
insulin on diabetic patients with good results.
Apollo announced to the ASX on the 14 november key
studies completed for trial.
They are confident they can deliver a therapeutic
dose of oral insulin across the bowel wall using
a matrix of carbohydrate nanoparticles coated in vitamin
B12.
An israli biotech company called oramed are also
developing an oral insulin.
Only a matter of time before oral insulin is on the
market.Great for diabetics.